Christopher Aker

Secretary & Vice President-Legal Affairs at Regulus Therapeutics, Inc.

Christopher Aker

Christopher Aker

Secretary & Vice President-Legal Affairs at Regulus Therapeutics, Inc.

Overview
Career Highlights

Cureline, Inc.

RelSci Relationships

86

Relationships
RelSci Relationships are individuals Christopher Aker likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Vice President, Human Capital at Regulus Therapeutics, Inc.

Relationship likelihood: Average

Chief Financial & Accounting Officer at Regulus Therapeutics, Inc.

Relationship likelihood: Average

Associate Director, CMC Analytical Development at Regulus Therapeutics, Inc.

Relationship likelihood: Average

Founder at SENTÉ, Inc. (California)

Relationship likelihood: Average

Professional at Juniper Point, Inc.

Relationship likelihood: Average

Advisor at Stanford University

Relationship likelihood: Average

President, Chief Executive Officer & Director at Synthorx, Inc.

Relationship likelihood: Average

Former Senior Research Investigator & Oncology Therapeutic Area Head, Oncology Research Unit at Pfizer, Inc.

Relationship likelihood: Average

Executive Officer at Phenomix Corp.

Relationship likelihood: Average

Chief Research & Development Officer at Regulus Therapeutics, Inc.

Relationship likelihood: Average

In The News
ICT Monitor Worldwide
November 22, 2016
Linode Opens Second Tokyo Datacenter
Philadelphia Inquirer
December 28, 2015
MOVING WHERE TECH TALENT IS
Paths to Christopher Aker
Potential Connections via
Relationship Science
You
Christopher Aker
Secretary & Vice President-Legal Affairs at Regulus Therapeutics, Inc.
Education

The University of California, Davis (also referred to as UCD, UC Davis, or Davis) is a public teaching and research university located in Davis, California just west of Sacramento. The campus covers 7,309 acres (2,958 ha), making it the largest within the 10 campus University of California system. UC Davis also has the third largest enrollment in the UC System after UCLA and UC Berkeley. The University of California, Davis campus is the largest campus in the UC system by land area, spanning 7,309 acres (2,957.8 ha) across two counties: Yolo and Solano. Though named after the City of Davis, the campus is technically located adjacent to the City of Davis in an unincorporated part of Yolo and Solano counties. The main campus is located 15 miles (24.1 km) west of Sacramento in the Sacramento Valley, part of California's Central Valley, and is adjacent to Interstate Highway 80. The Davis campus is the only school within the UC system with an airport, just west of main campus, and is one of two UC schools with its own fire department; the other being UC Santa Cruz. The campus is also conveniently located approximately an hour away from both San Francisco and the Napa Valley and two hours from Lake Tahoe. It is also one of only three schools in the University of California system, the others being UC Berkeley and UC Irvine, with a nuclear lab.

Santa Clara University, a comprehensive Jesuit, Catholic university located in California's Silicon Valley, offers its more than 8,000 students rigorous undergraduate curricula in arts and sciences, business, and engineering, plus master's, Ph.D., and law degrees. Distinguished nationally by the fourth-highest graduation rate among all U.S. master's universities, California's oldest operating higher-education institution demonstrates faith-inspired values of ethics and social justice.

Career History
Secretary & Vice President-Legal Affairs
2011 - Current

Regulus Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug product candidates in renal, hepatic, and central nervous systems diseases. The company was founded in September 2007 and is headquartered in San Diego, CA.

General Counsel
Prior
Senior Director-Administration & Corporate Counsel
Prior

Phenomix Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. It's internally discovered product candidates are designed to have improved efficacy, safety or convenience relative to existing therapies and other product candidates in clinical development. Its lead product candidate, dutogliptin tartrate, is a dipeptidyl peptidase-4, or DPP-4, inhibitor that it is developing as an oral, once-daily treatment for Type 2 diabetes. Its Phase 2b clinical trial of dutogliptin demonstrated statistically significant reductions in HbA1c when administered in combination with existing drugs for the treatment of Type 2 diabetes. The company commenced its Phase 3 clinical program in the third quarter of 2008. Its second product candidate, PHX1766, is a protease inhibitor currently in Phase 1 of clinical development for the treatment of hepatitis C virus, or HCV, infection.The company intends to maximize the value of its product candidates through independent development, licensing and other partnership opportunities. These may include co-development or co-marketing agreements, licensing agreements with pharmaceutical and biotechnology companies that possess established development and commercialization capabilities or direct commercialization by building its own sales and marketing force.

Political Donations
$500
2008

NO on 8-Equality for All campaign is a large and diverse coalition of civil rights, faith, choice, labor and community of color organizations working to stop and defeat any ballot measure that would deny same-sex couples the right to marry in California.

Transactions
Details Hidden

Regulus Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Regulus Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Regulus Therapeutics, Inc. raised money in a private placement transaction

Other Affiliations

Christopher Aker is affiliated with Regulus Therapeutics, Inc., Cureline, Inc., Phenomix Corp., Sugen LLC

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christopher Aker. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christopher Aker's profile does not indicate a business or promotional relationship of any kind between RelSci and Christopher Aker.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/christopher-aker-4937418
  • https://relationshipscience.com/person/christopher-aker-4937418